1988
DOI: 10.1016/0022-4731(88)90133-1
|View full text |Cite
|
Sign up to set email alerts
|

A correlative study of RU38486 biopotency and competition with [3H]dexamethasone for receptors in the rat central nervous system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1989
1989
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(5 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…Mifepristone has somewhat limited blood-brain barrier permeability, but the concentrations attained in the brain are still significant (almost one-third those of serum; Heikinheimo and Kekkonen, 1993). Accordingly, systemic mifepristone administration produces behavioral changes (Roberts et al, 1995; Koenig and Olive, 2004; Simms et al, 2011), inhibits neurogenesis (Oomen et al, 2007), and, most directly, competes with dexamethasone for binding sites in the rat central nervous system (Allen et al, 1988). Our results likewise suggest that mifepristone reaches central GRs at concentrations sufficient for receptor occupancy.…”
Section: Discussionmentioning
confidence: 99%
“…Mifepristone has somewhat limited blood-brain barrier permeability, but the concentrations attained in the brain are still significant (almost one-third those of serum; Heikinheimo and Kekkonen, 1993). Accordingly, systemic mifepristone administration produces behavioral changes (Roberts et al, 1995; Koenig and Olive, 2004; Simms et al, 2011), inhibits neurogenesis (Oomen et al, 2007), and, most directly, competes with dexamethasone for binding sites in the rat central nervous system (Allen et al, 1988). Our results likewise suggest that mifepristone reaches central GRs at concentrations sufficient for receptor occupancy.…”
Section: Discussionmentioning
confidence: 99%
“…Mifepristone or its vehicle (0.05% Tween 80 in distilled water) were given as a single dose intraperitoneally, immediately prior to withdrawal of the alcohol in all experiments. The dose for the majority of the experiments was 50 mg/kg, which has been previously shown to prevent the effects of exposure to chronic unpredictable stress in vivo on hippocampal calcium currents recorded subsequently in vitro (Moldow et al., 2005), to prevent the reduction of neurogenesis in rats caused by chronic corticosterone administration (Meyer et al., 2006) and to prevent binding of dexamethasone to the Type II glucocorticoid receptor (Allen et al., 1988), while a 40 mg/kg dose was found to prevent the facilitation of long term depression (LTD) caused in hippocampal neurons by restraint stress (Chaouloff et al., 2007). In the odor habituation and discrimination test the dose was lowered to 25 mg/kg in order to see whether or not the previously demonstrated effect of mifepristone in the object recognition experiments was seen using a lower mifepristone dose and a different memory test.…”
Section: Methodsmentioning
confidence: 99%
“…The GR and MR are also both able to bind the synthetic glucocorticoid, dexamethasone (DEX). However, unlike the endogenous glucocorticoids, DEX has greater preference for binding for the GR over the MR (Allen et al, 1988; Brinton and McEwen, 1988; Burgess and Handa, 1992). RU28362 is another synthetic glucocorticoid, but it is a selective agonist for the GR, with no apparent binding affinity for the MR (Coirini et al, 1985; Philibert and Moguilewsky, 1983; Quirk and Funder, 1988), and a Kd for the GR in the low nanomolar range.…”
Section: Mineralocorticoid and Glucocorticoid Receptorsmentioning
confidence: 99%